-
FAST&FURIOUSHEOR IMPACT:THE AI ASSISTANT PLAYBOOKTO BUILDTRUSTAND RESILIENCYINTHEFAST-PACED WORLD OFLARGE LANGUAGE MODELS (LLMS)
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK STRATIFICATION USING UNSUPERVISED MACHINE LEARNING IN BREAST CANCER PATIENTS, INITIATING ANTHRACYCLINE-BASED TREATMENTS
Mar 18, 2026, 21:38 PM -
REAL-WORLD REFERRAL PATTERNS AND HEALTHCARE UTILIZATION OF HEADACHE DISORDER PATIENTS IN THE UNITED KINGDOM (UK)
Mar 18, 2026, 21:38 PM -
REAL-WORLD UTILIZATION AND TREATMENT ADHERENCE OF BRAND AND GENERIC CYCLOSPORINE OPHTHALMIC EMULSION IN DRY EYE DISEASE
Mar 18, 2026, 21:38 PM -
TITLE: COST-UTILITY ANALYSIS OF CALCITONIN GENE-RELATED PEPTIDE ANTIBODIES FOR PATIENTS WITH CHRONIC MIGRAINE: A UNITED STATES PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
REAL-WORLD OUTCOMES OF MECHANICAL, PORCINE, AND DURABLE VALVES IN SEVERE AORTIC STENOSIS: SURVIVAL, REINTERVENTION, AND EARLY MORTALITY ANALYSIS
Mar 18, 2026, 21:38 PM -
PATTERNS AND PREDICTORS OF ANTIDEPRESSANT USE AMONG ADULTS WITH DEPRESSION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
EXPLORING THE OPTIMAL SHARE OF PHARMACEUTICAL VALUE FOR INDUSTRY AND SOCIETY: AN APPLICATION TO THE US CONTEXT
Mar 18, 2026, 21:38 PM -
LEVERAGING INVERSE PROBABILITY WEIGHTING TO ADDRESS TIME-DEPENDENT BIAS INTRODUCED BY NONRESPONSE IN REAL-WORLD LONGITUDINAL RESEARCH INVOLVING PATIENT-REPORTED OUTCOME MEASURES
Mar 18, 2026, 21:38 PM -
INCORPORATING REAL-WORLD EVIDENCE INTO TIME-TO-EVENT EXTRAPOLATIONS FROM CLINICAL TRIAL DATA
Mar 18, 2026, 21:38 PM -
EVALUATING THE ECONOMIC VALUE OF MONOCLONAL ANTIBODIES FOR AQP4+ NMOSD IN THE US USING ATTACK-FREE SURVIVAL OVER A 5-YEAR HORIZON
Mar 18, 2026, 21:38 PM -
RENAL RISK STRATIFICATION IN ON-PUMP AND OFF-PUMP CORONARY ARTERY BYPASS SURGERY
Mar 18, 2026, 21:38 PM -
REAL-WORLD SURVIVAL OUTCOMES IN KRAS(G12C) METASTATIC COLORECTAL CANCER IN THE UNITED STATES AND CANADA: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
COMPARING 1.5% RUXOLITINIB CREAM AND OTHER THERAPIES FOR PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF EXTENDED-RELEASE NALTREXONE WITH MOBILE MEDICAL TREATMENT VERSUS STANDARD DELIVERY FOLLOWING INCARCERATION
Mar 18, 2026, 21:38 PM -
VALIDATION OF THE PHENYLKETONURIA-SYMPTOM SEVERITY AND IMPACTS SCALE (PKU-SSIS) IN ADULTS WITH PKU
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF CRS AND ICANS SEVERITY ACROSS SIX COMMERCIAL CAR-T THERAPIES
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ONCOLOGY MEDICINES IN LATIN AMERICA: AVAILABILITY AND TIME-TO-ACCESS ACROSS HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
BEYOND “CURED”: PREFERRED TERMINOLOGY, MILESTONES, AND EVIDENCE FOR PAYER DECISION-MAKING IN EARLY-STAGE MELANOMA
Mar 18, 2026, 21:38 PM -
NOVEL THERAPIES FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA POST BRUTON’S TYROSINE KINASE INHIBITOR: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM
